Key points are not available for this paper at this time.
Despite the potential for residual axillary disease after SLND, SLND without ALND offers excellent regional control for selected patients with early metastatic breast cancer treated with breast-conserving therapy and adjuvant systemic therapy.
Giuliano et al. (Wed,) studied this question.